LDLRAD4 and what we know about it (WP4904)

Homo sapiens

A recent GWAS study was tweeted (https://twitter.com/BrentRichards19/status/1251550109931888643) showing an intronic SNP in LDLRAD4 as relevant. This pathway summarizes what is known of the biological role of this gene and its proteins.


Egon Willighagen , Friederike Ehrhart , and Eric Weitz


last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.


Homo sapiens




Pathway Ontology

disease pathway

Disease Ontology

disease by infectious agent


Label Type Compact URI Comment
PMEPA1 GeneProduct ensembl:ENSG00000124225 Also known as TMEPAI
NEDD4 GeneProduct ensembl:ENSG00000069869
LDLRAD4 GeneProduct ensembl:ENSG00000168675 Also known as C18ORF1
SMAD2 GeneProduct ensembl:ENSG00000175387
ATG16L1 GeneProduct ensembl:ENSG00000085978
TGFBR2 GeneProduct ensembl:ENSG00000163513
LDLRAD4 GeneProduct ensembl:ENSG00000168675 Also known as C18ORF1
SMAD2 GeneProduct ensembl:ENSG00000175387
TGFBR1 GeneProduct ensembl:ENSG00000106799
LDLRAD4 GeneProduct ensembl:ENSG00000168675 Also known as C18ORF1
NEDD4 GeneProduct ensembl:ENSG00000069869


  1. Genome-wide association study of blood pressure and hypertension. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Nat Genet. 2009 Jun;41(6):677–87. PubMed Europe PMC Scholia
  2. TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells. Vo Nguyen TT, Watanabe Y, Shiba A, Noguchi M, Itoh S, Kato M. Cancer Sci. 2014 Mar;105(3):334–41. PubMed Europe PMC Scholia
  3. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling. Nakano N, Maeyama K, Sakata N, Itoh F, Akatsu R, Nakata M, et al. J Biol Chem. 2014 May 2;289(18):12680–92. PubMed Europe PMC Scholia
  4. MiR-20a-5p mediates hypoxia-induced autophagy by targeting ATG16L1 in ischemic kidney injury. Wang IK, Sun KT, Tsai TH, Chen CW, Chang SS, Yu TM, et al. Life Sci. 2015 Sep 1;136:133–41. PubMed Europe PMC Scholia
  5. The BioPlex Network: A Systematic Exploration of the Human Interactome. Huttlin EL, Ting L, Bruckner RJ, Gebreab F, Gygi MP, Szpyt J, et al. Cell. 2015 Jul 16;162(2):425–40. PubMed Europe PMC Scholia
  6. Low density lipoprotein receptor class A domain containing 4 (LDLRAD4) promotes tumorigenesis of hepatic cancer cells. Liu Z, Huo X, Zhao S, Yang J, Shi W, Jing L, et al. Exp Cell Res. 2017 Nov 15;360(2):189–98. PubMed Europe PMC Scholia
  7. TMEPAI family: involvement in regulation of multiple signalling pathways. Itoh S, Itoh F. J Biochem. 2018 Sep 1;164(3):195–204. PubMed Europe PMC Scholia
  8. A large data resource of genomic copy number variation across neurodevelopmental disorders. Zarrei M, Burton CL, Engchuan W, Young EJ, Higginbotham EJ, MacDonald JR, et al. NPJ Genom Med. 2019 Oct 7;4:26. PubMed Europe PMC Scholia
  9. Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report. Yrondi A, Fiori LM, Frey BN, Lam RW, MacQueen GM, Milev R, et al. Int J Neuropsychopharmacol. 2020 Feb 1;23(2):88–95. PubMed Europe PMC Scholia
  10. Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer. Mo S, Zhang L, Dai W, Han L, Wang R, Xiang W, et al. Cell Death Dis. 2020 Feb 28;11(2):155. PubMed Europe PMC Scholia